Are Analysts Bearish Inovalon Holdings, Inc. (NASDAQ:INOV) After Last Week?

May 19, 2018 - By Marguerite Chambers

Inovalon Holdings, Inc. (NASDAQ:INOV) Logo

Inovalon Holdings, Inc. (NASDAQ:INOV) Ratings Coverage

Among 3 analysts covering Inovalon Holdings (NASDAQ:INOV), 0 have Buy rating, 2 Sell and 1 Hold. Therefore 0 are positive. Inovalon Holdings had 3 analyst reports since February 21, 2018 according to SRatingsIntel. The stock of Inovalon Holdings, Inc. (NASDAQ:INOV) has “Underweight” rating given on Wednesday, March 14 by Morgan Stanley. The firm has “Market Perform” rating by Wells Fargo given on Wednesday, February 21. On Wednesday, February 21 the stock rating was maintained by Piper Jaffray with “Sell”. Below is a list of Inovalon Holdings, Inc. (NASDAQ:INOV) latest ratings and price target changes.

14/03/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Underweight Old Target: $14 Downgrade
21/02/2018 Broker: Piper Jaffray Rating: Sell New Target: $8.0 Maintain
21/02/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $16 New Target: $14 Maintain

The stock increased 0.98% or $0.1 during the last trading session, reaching $10.3. About 608,089 shares traded. Inovalon Holdings, Inc. (NASDAQ:INOV) has declined 14.88% since May 19, 2017 and is downtrending. It has underperformed by 26.43% the S&P500.

Inovalon Holdings, Inc., a technology company, provides cloud platforms empowering a data-driven transformation from volume to value models throughout the healthcare industry. The company has market cap of $1.57 billion. The firm through, large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, enables the assessment and improvement of clinical and quality outcomes, and financial performance across the healthcare ecosystem. It has a 43.28 P/E ratio. It serves health plans and well-known provider organizations, as well as pharmaceutical, medical device, and diagnostics companies.

More important recent Inovalon Holdings, Inc. (NASDAQ:INOV) news were published by: Globenewswire.com which released: “Inovalon Announces First Quarter 2018 Earnings Conference Call” on April 25, 2018, also Seekingalpha.com published article titled: “Inovalon’s (INOV) CEO Keith Dunleavy on Q1 2018 Results – Earnings Call Transcript”, Globenewswire.com published: “Inovalon Reports First Quarter 2018 Results” on May 08, 2018. More interesting news about Inovalon Holdings, Inc. (NASDAQ:INOV) was released by: Nasdaq.com and their article: “Research Report Identifies Cracker Barrel Old Country Store, Enova International, Natera, Inovalon, UMH Properties …” with publication date: May 01, 2018.

Inovalon Holdings, Inc. (NASDAQ:INOV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.